Lindbrook Capital’s Myovant Sciences Ltd. MYOV Stock Holding History

Lindbrook Capital’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-90	Closed	-$2.43K	–	2960
2022 Q4	$2.43K	Hold	90	–	–	﹤0.01%	2159
2022 Q3	$2K	Hold	90	–	–	﹤0.01%	2196
2022 Q2	$1K	Sell	90 -50	-36%	-$552	﹤0.01%	2442
2022 Q1	$2K	Buy	140 +50	+56%	+$670	﹤0.01%	2134
2021 Q4	$1K	Buy	+90	New	+$1.72K	﹤0.01%	2042
2021 Q3	–	Sell	-1,000	Closed	-$23K	–	2043
2021 Q2	$23K	Hold	1,000	–	–	0.01%	740
2021 Q1	$21K	Hold	1,000	–	–	﹤0.01%	751
2020 Q4	$28K	Sell	1,000 -4,000	-80%	-$77.9K	0.01%	584
2020 Q3	$70K	Buy	5,000 +4,500	+900%	+$83.7K	0.02%	278
2020 Q2	$10K	Buy	+500	New	+$6.8K	﹤0.01%	846

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's MYOV Position: Q1 2023 in Review

Lindbrook Capital sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 90 shares — an estimated $2.43K sold.

Lindbrook Capital first reported a position in MYOV in Q2 2020 and held it in 10 quarters. The position peaked at $70K in Q3 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Lindbrook Capital reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Lindbrook Capital sold 90 Myovant Sciences Ltd. shares in Q1 2023, an estimated $2.43K.
Lindbrook Capital first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 10 quarters.
Lindbrook Capital's Myovant Sciences Ltd. position peaked at $70K in Q3 2020.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.